SBC Medical Group Holdings Incorporated
SBC
$3.57
-$0.07-1.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -18.33% | -18.35% | -13.65% | -28.76% | 12.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.33% | -18.35% | -13.65% | -28.76% | 12.28% |
| Cost of Revenue | 29.41% | -2.44% | -37.24% | -44.43% | -28.55% |
| Gross Profit | -29.20% | -23.87% | -4.52% | -21.89% | 29.08% |
| SG&A Expenses | -51.17% | 22.79% | -8.33% | -28.88% | 115.87% |
| Depreciation & Amortization | 3.72% | 82.37% | -52.37% | -- | -- |
| Other Operating Expenses | -53.30% | 296.38% | 145.25% | 82.45% | -37.20% |
| Total Operating Expenses | -30.01% | 11.60% | -23.79% | -35.76% | 44.01% |
| Operating Income | 14.79% | -46.67% | -1.06% | -17.56% | -30.91% |
| Income Before Tax | 41.19% | -50.01% | 15.62% | -74.29% | -37.79% |
| Income Tax Expenses | -44.77% | 30.15% | 17.84% | -105.23% | -21.05% |
| Earnings from Continuing Operations | 352.75% | -86.85% | 14.62% | -53.98% | -64.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -443.75% | 125.24% | 40.00% | -107.73% | -100.54% |
| Net Income | 352.70% | -86.70% | 14.63% | -54.41% | -66.10% |
| EBIT | 14.79% | -46.67% | -1.06% | -17.56% | -30.91% |
| EBITDA | 11.95% | -45.98% | -2.55% | -22.00% | -36.28% |
| EPS Basic | 319.13% | -87.92% | 4.57% | -58.24% | -66.40% |
| Normalized Basic EPS | 29.01% | -54.25% | -11.46% | -18.56% | -36.85% |
| EPS Diluted | 319.13% | -87.92% | 4.57% | -18.12% | -66.40% |
| Normalized Diluted EPS | 29.01% | -54.25% | -11.46% | -18.56% | -36.85% |
| Average Basic Shares Outstanding | 7.94% | 9.89% | 9.64% | 9.09% | 0.96% |
| Average Diluted Shares Outstanding | 7.94% | 9.89% | 9.64% | 9.09% | 0.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |